Home LiteratureArticle Details
PMID: 12414501 Published · ppublish English Journal Article

ADAM12 alleviates the skeletal muscle pathology in mdx dystrophic mice.

The American journal of pathology ·Vol. 161 ·No. 5 ·2002-11-00 ·Pages 1535-40

Kronqvist P, Kawaguchi N, Albrechtsen R, Xu X, Schrøder HD, Moghadaszadeh B, Nielsen FC, Fröhlich C, Engvall E, Wewer UM

Abstract

Muscular dystrophy is characterized by muscle degeneration and insufficient regeneration and replacement of muscle fibers by connective tissue. New therapeutic strategies directed toward various forms of muscular dystrophy are needed to preserve muscle mass and promote regeneration. In this study we examined the role of the transmembrane ADAM12, a disintegrin and metalloprotease, which is normally associated with development and regeneration of skeletal muscle. We demonstrate that ADAM12 overexpression in the dystrophin-deficient mdx mice alleviated the muscle pathology in these animals, as evidenced by less muscle cell necrosis and inflammation, lower levels of serum creatine kinase, and less uptake of Evans Blue dye into muscle fibers. These studies demonstrate that ADAM12 directly or indirectly contributes to muscle cell regeneration, stability, and survival.

MeSH Terms
ADAM Proteins ADAM12 Protein Animals Humans Inflammation/pathology Membrane Proteins/genetics,physiology Metalloendopeptidases/genetics,physiology Mice Mice, Inbred mdx Mice, Transgenic Muscle, Skeletal/pathology Muscular Dystrophies/pathology Necrosis
Chemicals
Membrane Proteins ADAM Proteins ADAM12 Protein ADAM12 protein, human Metalloendopeptidases
Authors & Affiliations
10 authors, click to expand affiliations / ORCID
Kronqvist Pauliina
Institute of Molecular Pathology, University of Copenhagen, Denmark.
Kawaguchi Nobuko
Albrechtsen Reidar
Xu Xiufeng
Schrøder Henrik Daa
Moghadaszadeh Behzad
Nielsen Finn Cilius
Fröhlich Camilla
Engvall Eva
Wewer Ulla M
References (40)
40 references, click to expand
  1. 85th ENMC International Workshop on Congenital Muscular Dystrophy. 6th International CMD Workshop. 1st Workshop of the Myo-Cluster Project 'GENRE'. 27-28th October 2000, Naarden, The Netherlands.
    Neuromuscul Disord. 2002 Jan;12(1):69-78 PMID: 11731288
  2. Remarkable roles of proteolysis on and beyond the cell surface.
    Curr Opin Cell Biol. 2000 Oct;12(5):606-12 PMID: 10978897
  3. Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: metalloproteinase inhibitors as a new therapy.
    Nat Med. 2002 Jan;8(1):35-40 PMID: 11786904
  4. Muscular dystrophy--reason for optimism?
    Cell. 2002 Jan 11;108(1):5-8 PMID: 11792315
  5. Muscle-specific expression of insulin-like growth factor I counters muscle decline in mdx mice.
    J Cell Biol. 2002 Apr 1;157(1):137-48 PMID: 11927606
  6. Overexpression of the cytotoxic T cell GalNAc transferase in skeletal muscle inhibits muscular dystrophy in mdx mice.
    Proc Natl Acad Sci U S A. 2002 Apr 16;99(8):5616-21 PMID: 11960016
  7. ADAM 12 protease induces adipogenesis in transgenic mice.
    Am J Pathol. 2002 May;160(5):1895-903 PMID: 12000741
  8. A metalloprotease-disintegrin participating in myoblast fusion.
    Nature. 1995 Oct 19;377(6550):652-6 PMID: 7566181
  9. Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney.
    Nat Med. 1996 Apr;2(4):418-23 PMID: 8597951
  10. Visualization of dystrophic muscle fibers in mdx mouse by vital staining with Evans blue: evidence of apoptosis in dystrophin-deficient muscle.
    J Biochem. 1995 Nov;118(5):959-64 PMID: 8749313
  11. Growth hormone and the insulin-like growth factor system in myogenesis.
    Endocr Rev. 1996 Oct;17(5):481-517 PMID: 8897022
  12. Amelioration of the dystrophic phenotype of mdx mice using a truncated utrophin transgene.
    Nature. 1996 Nov 28;384(6607):349-53 PMID: 8934518
  13. Animal models for muscular dystrophy show different patterns of sarcolemmal disruption.
    J Cell Biol. 1997 Oct 20;139(2):375-85 PMID: 9334342
  14. A novel, secreted form of human ADAM 12 (meltrin alpha) provokes myogenesis in vivo.
    J Biol Chem. 1998 Jan 2;273(1):157-66 PMID: 9417060
  15. Heparin-binding EGF-like growth factor.
    Biochim Biophys Acta. 1997 Dec 9;1333(3):F179-99 PMID: 9426203
  16. Spatially- and temporally-restricted expression of meltrin alpha (ADAM12) and beta (ADAM19) in mouse embryo.
    Mech Dev. 1998 May;73(2):211-5 PMID: 9622634
  17. Merosin-deficient congenital muscular dystrophy. Partial genetic correction in two mouse models.
    J Clin Invest. 1998 Aug 15;102(4):844-52 PMID: 9710454
  18. ADAMs: focus on the protease domain.
    Curr Opin Cell Biol. 1998 Oct;10(5):654-9 PMID: 9818177
  19. A cellular striptease act.
    Science. 1998 Nov 13;282(5392):1279-80 PMID: 9867633
  20. Seeking muscle stem cells.
    Curr Top Dev Biol. 1999;43:191-219 PMID: 9891887
  21. Cysteine-rich domain of human ADAM 12 (meltrin alpha) supports tumor cell adhesion.
    Am J Pathol. 1999 May;154(5):1489-501 PMID: 10329602
  22. Aminoglycoside antibiotics restore dystrophin function to skeletal muscles of mdx mice.
    J Clin Invest. 1999 Aug;104(4):375-81 PMID: 10449429
  23. Disintegrin-like/cysteine-rich region of ADAM 12 is an active cell adhesion domain.
    Exp Cell Res. 1999 Nov 1;252(2):423-31 PMID: 10527632
  24. Muscle regeneration: molecular aspects and therapeutic implications.
    Curr Opin Neurol. 1999 Oct;12(5):535-43 PMID: 10590890
  25. The ADAM gene family: surface proteins with adhesion and protease activity.
    Trends Genet. 2000 Feb;16(2):83-7 PMID: 10652535
  26. Prevention of the dystrophic phenotype in dystrophin/utrophin-deficient muscle following adenovirus-mediated transfer of a utrophin minigene.
    Gene Ther. 2000 Feb;7(3):201-4 PMID: 10694796
  27. Binding of ADAM12, a marker of skeletal muscle regeneration, to the muscle-specific actin-binding protein, alpha -actinin-2, is required for myoblast fusion.
    J Biol Chem. 2000 May 5;275(18):13933-9 PMID: 10788519
  28. Deflazacort increases laminin expression and myogenic repair, and induces early persistent functional gain in mdx mouse muscular dystrophy.
    Cell Transplant. 2000 Jul-Aug;9(4):551-64 PMID: 11038071
  29. RGD-independent binding of integrin alpha9beta1 to the ADAM-12 and -15 disintegrin domains mediates cell-cell interaction.
    J Biol Chem. 2000 Nov 10;275(45):34922-30 PMID: 10944520
  30. ADAM 12-S cleaves IGFBP-3 and IGFBP-5 and is inhibited by TIMP-3.
    Biochem Biophys Res Commun. 2000 Nov 30;278(3):511-5 PMID: 11095942
  31. Analysis for transcript expression of meltrin alpha in normal, regenerating, and denervated rat muscle.
    J Muscle Res Cell Motil. 2000;21(5):475-80 PMID: 11129438
  32. Molecular basis of muscular dystrophies.
    Muscle Nerve. 2000 Oct;23(10):1456-71 PMID: 11003781
  33. Enhanced expression of the alpha 7 beta 1 integrin reduces muscular dystrophy and restores viability in dystrophic mice.
    J Cell Biol. 2001 Mar 19;152(6):1207-18 PMID: 11257121
  34. An agrin minigene rescues dystrophic symptoms in a mouse model for congenital muscular dystrophy.
    Nature. 2001 Sep 20;413(6853):302-7 PMID: 11565031
  35. A nitric oxide synthase transgene ameliorates muscular dystrophy in mdx mice.
    J Cell Biol. 2001 Oct 1;155(1):123-31 PMID: 11581289
  36. Dystrophin and muscular dystrophy: past, present, and future.
    Mol Genet Metab. 2001 Sep-Oct;74(1-2):75-88 PMID: 11592805
  37. The potential of muscle stem cells.
    Dev Cell. 2001 Sep;1(3):333-42 PMID: 11702945
  38. The cysteine-rich domain of human ADAM 12 supports cell adhesion through syndecans and triggers signaling events that lead to beta1 integrin-dependent cell spreading.
    J Cell Biol. 2000 May 29;149(5):1143-56 PMID: 10831617
  39. ADAM 12, a disintegrin metalloprotease, interacts with insulin-like growth factor-binding protein-3.
    J Biol Chem. 2000 Jun 16;275(24):18574-80 PMID: 10849447
  40. Therapeutic possibilities in muscular dystrophy: the hope versus the hype.
    Neuromuscul Disord. 2002 Feb;12(2):113-6 PMID: 11738351
Article Info
Journal
The American journal of pathology
Abbr.
Am J Pathol
ISSN
0002-9440
Published
2002-11-00
Pages
1535-40
Language
English
Region
United States
NLM ID
0370502
PMCID
PMC1850802
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com